China-Singapore Suzhou Industrial Park Development Group Co., Ltd. (601512.SH) has announced its plan to participate as a limited partner in the Anhui Daotong Yaohui Equity Investment Partnership (Limited Partnership), committing its own funds to the venture, with a maximum contribution of RMB 20 million.

The fund is dedicated to equity investments in the medical device and biotechnology sectors. In the current fundraising round, it aims to attract multiple investors, targeting a total scale not exceeding RMB 1.1 billion, with the final amount subject to actual fundraising results.

The company's capital contribution will not surpass RMB 20 million and will account for no more than 5% of the final target fund's total subscribed capital. This investment aligns with the company's strategic development plan, as it seeks to generate financial returns while optimizing its industrial investment portfolio.

By participating in this fund, the company aims to effectively supplement its park development and operations business chain, reinforce its core operations in this area, and enhance the overall competitiveness of its industrial park development and management capabilities.